An open label, multicenter, randomized, parallel controlled study to compare the efficacy and safety profile of chemo-radiotherapy with concomitant HMPL-002 use compared to standard chemo-radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer

Trial Profile

An open label, multicenter, randomized, parallel controlled study to compare the efficacy and safety profile of chemo-radiotherapy with concomitant HMPL-002 use compared to standard chemo-radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 23 Feb 2009

At a glance

  • Drugs Antineoplastics; HMPL 002
  • Indications Cancer; Non-small cell lung cancer
  • Focus Therapeutic Use
  • Sponsors Chi-Med; Hutchison MediPharma
  • Most Recent Events

    • 23 Feb 2009 New trial record.
    • 08 Feb 2009 Interim results data have been reported in a Chi-Med media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top